Proportion of subjects with insulin independence 75 days after first islet transplant [clinicaltrials_resource:15f46c2b16a180311b2ce5a9181730f1]
Participants will receive up to three islet transplantations and continuous immunosuppressive therapy including belatacept
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Proportion of subjects with insulin independence 75 days after first islet transplant [clinicaltrials_resource:15f46c2b16a180311b2ce5a9181730f1]
Participants will receive up to three islet transplantations and continuous immunosuppressive therapy including belatacept
Bio2RDF identifier
15f46c2b16a180311b2ce5a9181730f1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:15f46c2b16a180311b2ce5a9181730f1
measure [clinicaltrials_vocabulary:measure]
Proportion of subjects with insulin independence
time frame [clinicaltrials_vocabulary:time-frame]
75 days after first islet transplant
description
Participants will receive up t ...... e therapy including belatacept
identifier
clinicaltrials_resource:15f46c2b16a180311b2ce5a9181730f1
title
Proportion of subjects with insulin independence 75 days after first islet transplant
@en
type
label
Proportion of subjects with in ...... 46c2b16a180311b2ce5a9181730f1]
@en